solu-medrol
Showing 1 - 5 of 5
Systemic Lupus Erythematous (SLE) Trial run by the NIAMS (SOLU-MEDROL)
Recruiting
- Systemic Lupus Erythematous (SLE)
- SOLU-MEDROL
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)
Recruiting
- Hepatitis, Drug-Induced
- Mycophenolate Mofetil
- +3 more
-
Herlev, Copenhagen, Denmark
- +4 more
Dec 11, 2022
Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Nivolumab
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 9, 2021
Severe Ulcerative Colitis Patients Admitted for Intravenous
Unknown status
- Ulcerative Colitis
- Ultrasound Therapy; Complications
- Solu-Medrol
-
Copenhagen, Herlev, DenmarkHerlev University Hospital
Jan 26, 2021
Lymphoma, Non-Hodgkin Trial in Stanford (Cyclophosphamide, BCNU, Etoposide)
Terminated
- Lymphoma, Non-Hodgkin
- Cyclophosphamide
- +12 more
-
Stanford, CaliforniaStanford University School of Medicine
Jan 17, 2018